Palvella Therapeutics (PVLA) Cash from Investing Activities Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Cash from Investing Activities Growth (1y) (2015 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.42 Bn |
1.16 Bn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
107.16% |
| Jun 30, 2024 |
259.30% |
| Mar 31, 2024 |
-24.39% |
| Dec 31, 2023 |
211.56% |
| Sep 30, 2023 |
-136.27% |
| Jun 30, 2023 |
87.43% |
| Mar 31, 2023 |
170.23% |
| Dec 31, 2022 |
423.68% |
| Sep 30, 2022 |
1,662.86% |
| Jun 30, 2022 |
-4,644.54% |
| Mar 31, 2022 |
-60,428.57% |
| Dec 31, 2021 |
-102.30% |
| Sep 30, 2021 |
-101.91% |
| Jun 30, 2021 |
-104.09% |
| Mar 31, 2021 |
-106.76% |
| Dec 31, 2020 |
889.53% |
| Sep 30, 2020 |
345.09% |
| Jun 30, 2020 |
-56.66% |
| Mar 31, 2020 |
107.79% |
| Dec 31, 2019 |
63.94% |
